Gynecologic Oncology
Gynecologic oncology in Turkey focuses on the diagnosis, surgical treatment, systemic therapy, and follow-up of cancers affecting the female reproductive system. These cancers may involve the ovaries, uterus, cervix, vulva, vagina, or fallopian tubes. Treatment planning depends on cancer type, stage, pathology, molecular features, fertility considerations, previous therapies, and the patient’s overall health.

What Is Gynecologic Oncology?
Gynecologic oncology is a medical specialty dedicated to cancers of the female reproductive organs. Gynecologic oncologists are involved in diagnosis, staging, surgery, treatment planning, and long-term follow-up. Care may also include medical oncology, radiation oncology, pathology, radiology, genetics, and supportive care. Because each gynecologic cancer behaves differently, treatment should be based on the specific organ involved and the biological characteristics of the tumor.

Which Cancers Are Treated in Gynecologic Oncology?
Gynecologic oncology includes several different cancer types.
The most common are ovarian cancer, endometrial cancer, and cervical cancer.
The specialty also manages vulvar cancer, vaginal cancer, fallopian tube cancer, and selected gestational trophoblastic diseases.
Some tumors are diagnosed at an early stage and may be treated primarily with surgery.
Others require combinations of surgery, chemotherapy, radiotherapy, targeted therapy, or immunotherapy.
How Are Gynecologic Cancers Diagnosed?
Diagnosis usually begins with symptoms, physical examination, imaging, or abnormal screening results.
Ultrasound, CT, MRI, or PET-based imaging may be used depending on the suspected cancer.
A tissue sample is often required to confirm the diagnosis.
Biopsy may be obtained from the cervix, endometrium, vulva, or another affected area.
In ovarian cancer, definitive diagnosis may sometimes depend on tissue obtained during surgery.
Pathology determines the cancer type and provides information that influences treatment planning.
What Is Gynecologic Cancer Staging?
Staging describes how far a gynecologic cancer has spread.
The process may evaluate the primary tumor, lymph nodes, abdominal structures, and distant organs.
Different gynecologic cancers have different staging systems.
Imaging, surgery, pathology, and laboratory findings may all contribute to the final stage.
Accurate staging is important because treatment for localized disease can differ substantially from treatment for advanced or metastatic cancer.
What Is Ovarian Cancer?
Ovarian cancer develops from tissues involving the ovaries or closely related structures.
Epithelial ovarian cancer is the most common major category, but several histological subtypes exist.
Symptoms can be nonspecific and may include persistent bloating, abdominal discomfort, early fullness, or changes in bowel or urinary habits.
Treatment commonly involves surgery and chemotherapy.
The extent of surgery depends on disease distribution, tumor type, age, fertility goals, and whether complete or near-complete tumor removal appears feasible.
How Is Ovarian Cancer Surgery Performed?
Ovarian cancer surgery may involve removal of the ovaries, fallopian tubes, uterus, omentum, and visible tumor deposits.
The objective in advanced disease is often cytoreduction, meaning removal of as much visible cancer as possible.
Some operations require treatment of disease involving the bowel, diaphragm, spleen, or other abdominal structures.
Surgery may be performed before chemotherapy or after several chemotherapy cycles.
The sequence depends on disease extent, surgical feasibility, and the patient’s clinical condition.
What Is Endometrial Cancer?
Endometrial cancer begins in the lining of the uterus.
Abnormal uterine bleeding is one of its most important presenting symptoms, particularly after menopause.
Diagnosis usually requires sampling of the endometrium.
Many endometrial cancers are identified at an earlier stage than ovarian cancer.
Surgery often includes hysterectomy and removal of the fallopian tubes and ovaries.
Lymph node assessment may also be performed.
Additional radiotherapy or systemic treatment depends on stage, tumor grade, pathology, and molecular risk factors.
What Is Cervical Cancer?
Cervical cancer develops in the cervix and is strongly associated with persistent infection by high-risk human papillomavirus types.
Early cervical abnormalities may be detected through screening before invasive cancer develops.
Treatment depends heavily on stage.
Small early-stage cancers may be treated surgically in selected patients.
More locally advanced disease is often treated with radiotherapy combined with chemotherapy.
Brachytherapy can form an important part of definitive radiation treatment for cervical cancer.
Can Fertility Be Preserved During Treatment?
Fertility-preserving treatment may be possible in carefully selected patients with certain early-stage gynecologic cancers.
The option depends on cancer type, stage, tumor characteristics, age, and future pregnancy plans.
Selected early cervical cancers may sometimes be managed with fertility-preserving surgery.
Certain low-risk endometrial cancers may occasionally be treated conservatively under close monitoring.
Some ovarian tumors may allow preservation of the unaffected ovary and uterus.
Cancer control remains the primary consideration when evaluating fertility-preserving approaches.
What Is Minimally Invasive Gynecologic Cancer Surgery?
Minimally invasive surgery uses laparoscopic or robotic techniques through smaller abdominal incisions.
It may be appropriate for selected endometrial cancers and other gynecologic procedures.
Potential benefits can include reduced postoperative pain, smaller scars, and shorter recovery.
However, the surgical approach must remain appropriate for the specific cancer.
Tumor type, size, stage, previous surgery, and oncological safety influence whether open or minimally invasive surgery is preferred.
What Is Sentinel Lymph Node Mapping?
Sentinel lymph node mapping identifies the first lymph nodes that are most likely to receive cancer cells from a primary tumor.
It is increasingly used in selected endometrial, cervical, and vulvar cancers.
A tracer helps surgeons locate the sentinel nodes during surgery.
These nodes are removed and examined by pathology.
When appropriate, this approach may reduce the need for extensive lymph node removal.
It can therefore lower the risk of complications such as lymphedema while still providing important staging information.
When Is Chemotherapy Used?
Chemotherapy is used in several gynecologic cancers, particularly ovarian cancer and selected advanced or high-risk uterine cancers.
It may be given after surgery, before surgery, or as the main systemic treatment for advanced disease.
Drug combinations vary according to tumor type and previous treatment.
Treatment response is monitored using symptoms, imaging, laboratory results, and sometimes tumor markers.
Chemotherapy may also be combined with targeted therapy or other systemic treatments in selected cases.
What Role Does Radiotherapy Play?
Radiotherapy is particularly important in cervical, endometrial, vaginal, and vulvar cancers.
External beam radiotherapy can target the pelvis or other defined areas.
Brachytherapy places a radiation source close to the tumor and is frequently used in cervical cancer treatment.
Radiotherapy may be given after surgery to reduce recurrence risk or used as the main treatment when surgery is not appropriate.
Treatment selection depends on stage, surgical findings, lymph node involvement, margins, and tumor biology.
Are Targeted Therapies Used in Gynecologic Oncology?
Targeted therapy is used for selected gynecologic cancers when appropriate biological features are present.
Some ovarian cancers may be treated with PARP inhibitors depending on genetic or molecular characteristics.
Anti-angiogenic treatments can also be used in selected ovarian or cervical cancer settings.
Molecular testing may help identify patients who could benefit from these therapies.
Targeted treatment does not replace standard surgery or chemotherapy in every case and should be integrated according to the overall treatment strategy.
Is Immunotherapy Used for Gynecologic Cancers?
Immunotherapy can be used in selected advanced or recurrent gynecologic cancers.
Its role has expanded in cervical and endometrial cancer, particularly when tumors show relevant biomarkers or meet specific treatment criteria.
Checkpoint inhibitors help immune cells recognize cancer more effectively.
Treatment may be given alone or combined with other therapies.
Potential immune-related side effects can affect organs including the skin, lungs, bowel, liver, and endocrine glands.
Patients therefore require structured monitoring during treatment.
What Is Genetic Testing in Gynecologic Oncology?
Genetic and molecular testing can influence both treatment and family risk assessment.
Selected ovarian cancers may be associated with inherited BRCA1 or BRCA2 mutations.
Endometrial cancer can sometimes be related to Lynch syndrome.
Testing may identify inherited cancer susceptibility and can also influence targeted treatment options.
Tumor testing and inherited genetic testing are different processes.
Genetic counseling can help explain whether testing has implications for relatives as well as for the patient’s treatment.
What Is Recovery Like After Gynecologic Cancer Surgery?
Recovery depends on the extent and type of surgery.
Smaller minimally invasive procedures generally have a different recovery period from extensive cytoreductive operations.
Patients may experience fatigue, abdominal discomfort, temporary bowel changes, or reduced mobility.
Walking is usually encouraged as recovery progresses.
Pathology results are reviewed after surgery to determine the final stage and whether additional chemotherapy or radiotherapy is needed.
Long-term follow-up may also address menopause, sexual health, fertility, and lymphedema.
Gynecologic Oncology in Turkey for International Patients
International patients considering gynecologic oncology in Turkey should provide complete medical records before treatment planning.
Useful documents may include pathology reports, biopsy results, imaging, previous surgery records, chemotherapy history, cervical screening results, and molecular or genetic tests.
Complex cases may benefit from multidisciplinary review before treatment begins.
Travel plans should account for diagnostic reassessment, surgery, pathology review, chemotherapy, radiotherapy, and postoperative follow-up when required.
Gynecologic oncology in Turkey can include diagnosis, cancer surgery, chemotherapy, radiotherapy, targeted therapy, immunotherapy, fertility considerations, and genetic evaluation. Accurate staging, specialized pathology, appropriate treatment sequencing, and multidisciplinary follow-up remain central to gynecologic cancer care.

You can send us messages regarding your appointments and requests.